The study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment
The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.